NCT05104398View on ClinicalTrials.gov

Hemoperfusion With the Efferon CT Extracorporeal Adsorbers in Patients With Severe Covid-19

CompletedOBSERVATIONAL
Enrollment

42

Participants

Timeline

Start Date

October 1, 2020

Primary Completion Date

January 30, 2021

Study Completion Date

July 30, 2021

Conditions
COVID-19
Interventions
DEVICE

Efferon CT

extracorporeal adsorbers containing mesoporous styrene-divinylbenzene copolymer to remove pro-inflammatory 6-60 kD molecules

Trial Locations (1)

119049

N.I. Pirogov City Clinical Hospital No. 1, Moscow

All Listed Sponsors
lead

Efferon JSC

INDUSTRY

NCT05104398 - Hemoperfusion With the Efferon CT Extracorporeal Adsorbers in Patients With Severe Covid-19 | Biotech Hunter | Biotech Hunter